Next-Gen Sequencing Could Unlock Ebola’s Secrets
The Ebola outbreak in West Africa has dominated recent newscasts and shocked many people
Drug Development Gets Even More Personal, Precise
As we’ve discussed, Eric Topol’s “How to Change Medicine” provides valuable insights on how tailoring
Roche’s Proposed Takeover of Illumina—Game On for
There appears to be a full-scale race underway to bring affordable next-gen DNA sequencing
Through the Murky Slog: Part II—A New
Last week, we discussed new drug approvals that reflected a paradigm shift for cancer
Seeking Holy Grail: Quest for Stem Cells
In a recent paper that spawned news articles and blogs worldwide, researchers announced the generation of human
Treating Cancer – Moving Beyond the Whack-a-Mole
In his latest Wall Street Journal column (“Drugs That Are as Smart as Our
Companion Diagnostics: More Targeted Medicine on the
It’s increasingly clear to anyone who deals with human health – from the bench
#Bio2011: After the Party is Over
For the thousands of life science industry representatives who attend the Biotechnology Industry Organization Annual